Covestor’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1K Sell
20
-13
-39% -$345 ﹤0.01% 2019
2026
Q2
$1K Buy
33
+24
+267% +$371 ﹤0.01% 2029
2026
Q1
$0 Buy
+9
New +$127 ﹤0.01% 2217
2024
Q3
– Sell
-43
Closed – – 2166
2024
Q2
$0 Sell
43
-31
-42% -$60 ﹤0.01% 2200
2024
Q1
$0 Sell
74
-3,652
-98% -$47.8K ﹤0.01% 2196
2023
Q4
$55K Buy
3,726
+3,722
+93,050% +$57K 0.04% 804
2023
Q3
$0 Hold
4
– – ﹤0.01% 2069
2023
Q2
$0 Hold
4
– – ﹤0.01% 2089
2023
Q1
$0 Hold
4
– – ﹤0.01% 1969
2022
Q4
$0 Sell
4
-1
-20% -$35 ﹤0.01% 2015
2022
Q3
$0 Buy
+5
New +$125 ﹤0.01% 1933

Other funds holding AMLX

Covestor's AMLX Position: Q3 2026 in Review

Covestor reduced its Amylyx Pharmaceuticals (AMLX) stake by 39% in Q3 2026, selling an estimated $345 and leaving 20 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2019.

Covestor first reported a position in AMLX in Q3 2022 and has held it in 11 quarters since. The position peaked at $55K in Q4 2023. 147 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.

  • Covestor held 20 shares of Amylyx Pharmaceuticals worth $1K as of Q3 2026.
  • Covestor sold 13 Amylyx Pharmaceuticals shares in Q3 2026, an estimated $345.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2019 holding.
  • Covestor first reported a position in Amylyx Pharmaceuticals in Q3 2022 and has held it in 11 quarters since.
  • Covestor's Amylyx Pharmaceuticals position peaked at $55K in Q4 2023.
  • 147 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.